63% of patients with upper tract urothelial carcinoma respond to chemo before surgeryFebruary 24, 2022Genitourinary CancerOncology
MRI far safer than CT for guiding radiotherapy in prostate cancerFebruary 24, 2022Genitourinary CancerOncologyProstate Cancer
Twitter storm over ‘reprehensible behavior’ at conference podiumFebruary 22, 2022Genitourinary Cancer
“I didn’t want to meet you.” Dispelling myths about palliative careFebruary 2, 2022Mixed TopicsHead & Neck/Thyroid CancersGenitourinary CancerLung CancerMelanomaLeukemia, Myelodysplasia, TransplantationOncology
Cancer risk tied to some manufactured foodsDecember 16, 2021Breast CancerOncologyGenitourinary Cancer
Shock, disbelief as NCCN changes prostate cancer guidanceNovember 15, 2021Genitourinary CancerOncology
Urine test for prostate cancer signals amount of aggressive tumorNovember 11, 2021Genitourinary CancerProstate CancerOncology
Severe COVID two times higher for cancer patientsNovember 8, 2021Breast CancerOncologyHead & Neck/Thyroid CancersGenitourinary CancerLeukemia, Myelodysplasia, TransplantationMultiple MyelomaLung Cancer
Overall survival for metastatic urothelial carcinoma approaching 2 yearsNovember 2, 2021Genitourinary CancerOncology
Antibiotic and glucocorticoid use before cancer therapy could have detrimental effect on outcomesOctober 28, 2021Lung CancerOncologyBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersMelanoma
Many patients, doctors unaware of advancements in cancer careOctober 4, 2021Mixed TopicsOncologyBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung Cancer
